CorMedix (NYSEMKT:CRMD): Q3 GAAP EPS of -$0.22 beats by $0.04.
Revenue of $0.93M (+1450.0% Y/Y) beats by $0.89M.
Shares +1.5% AH.
Glaukos (NYSE:GKOS): Q3 Non-GAAP EPS of -$0.09 beats by $0.39; GAAP EPS of -$0.35 beats by $0.20.
Revenue of $64.8M (+10.8% Y/Y) beats by $11.06M.
Shares +2.7% AH.
Oyster Point Pharma (NASDAQ:OYST): Q3 GAAP EPS of -$0.63 beats by $0.11.
Cash and cash equivalents of $214.3M.
AtriCure (NASDAQ:ATRC): Q3 GAAP EPS of -$0.11 beats by $0.23.
Revenue of $54.76M (-3.3% Y/Y) beats by $5.39M.
Shares +1.7% AH.
Neovasc (NASDAQ:NVCN): Q3 GAAP EPS of -$0.51 beats by $0.02.
Revenue of $0.63M (+26.0% Y/Y) beats by $0.08M.
Shares -2.1% AH.